T17S (p.Thr17Ser) variant of CTLA4 (Cytotoxic T-lymphocyte protein 4)

T17S (p.Thr17Ser) in CTLA4 (Cytotoxic T-lymphocyte protein 4) is a missense change. Clinical records from EBI and UniProt describe it as benign. The available variant effect predictions contribute to a CATVariant prioritization score of 0.12 / 1. The record also includes population frequency data and structural context.

T17S (p.Thr17Ser) variant details